HemoGenyx Pharmaceuticals Plc's total assets for Q2 2025 were £3.10M, a decrease of -26.36% from the previous quarter. GB:HEMO total liabilities were £3.65M for the fiscal quarter, a 8.62% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.